XML 19 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Revision of Prior Period, Accounting Standards Update, Adjustment [Member]
Accumulated Deficit [Member]
Revision of Prior Period, Accounting Standards Update, Adjustment [Member]
Total
Balance at Dec. 31, 2018 $ 150 $ 1,096,053 $ (36)   $ (982,106)   $ 114,061
Balance, shares at Dec. 31, 2018 150,244            
Net (loss) income         (84,134)   (84,134)
Other comprehensive income loss     41       41
Issuance of common stock in conjunction with equity plans $ 3 8,545         8,548
Issuance of common stock in conjunction with equity plans, shares 2,875            
Stock-based compensation expense   16,401         16,401
Balance at Dec. 31, 2019 $ 153 1,120,999 5   (1,066,240)   54,917
Balance, shares at Dec. 31, 2019 153,119            
Net (loss) income         29,403   29,403
Other comprehensive income loss     80       80
Issuance of common stock in conjunction with equity plans $ 10 46,350         46,360
Issuance of common stock in conjunction with equity plans, shares 9,819            
Issuance of common stock from underwritten public equity offering, net of issuance costs $ 29 187,201         187,230
Issuance of common stock from underwritten public equity offering, net of issuance costs, shares 29,356            
Stock-based compensation expense   17,533         17,533
Balance (Accounting Standards Update, Topic 326 [Member]) at Dec. 31, 2020       $ (32)   $ (32)  
Balance at Dec. 31, 2020 $ 192 1,372,083 85   (1,036,869)   $ 335,491
Balance, shares at Dec. 31, 2020 192,294           192,294
Net (loss) income         (181,223)   $ (181,223)
Other comprehensive income loss     (1,172)       (1,172)
Issuance of common stock in conjunction with equity plans $ 9 31,797         31,806
Issuance of common stock in conjunction with equity plans, shares 8,557            
Issuance of common stock in Private Placement, net of issuance costs $ 11 294,834         294,845
Issuance of common stock in Private Placement, net of issuance costs shares 11,215            
Issuance of common stock in acquisition of Omniome $ 9 237,876         237,885
Issuance of common stock in acquisition of Omniome, shares 8,912            
Stock-based compensation expense   73,355         73,355
Balance at Dec. 31, 2021 $ 221 $ 2,009,945 $ (1,087)   $ (1,218,092)   $ 790,987
Balance, shares at Dec. 31, 2021 220,978           220,978